Neil S. Chua

Edmonton, AB, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trial.

Structured exercise program following adjuvant chemotherapy for colon cancer: A cost-utility analysis of the CHALLENGE trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 31, 2026

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial.

Structured Exercise Program After Adjuvant Chemotherapy for Colon Cancer: A Cost-Utility Analysis of the CHALLENGE Trial.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 31, 2026

Phase I/II Trial of Durvalumab plus Tremelimumab and Stereotactic Body Radiotherapy for Metastatic Head and Neck Carcinoma.

Phase I/II Trial of Durvalumab plus Tremelimumab and Stereotactic Body Radiotherapy for Metastatic Head and Neck Carcinoma.

Journal: International journal of radiation oncology, biology, physics

Published: February 10, 2026

Effects of a structured exercise program on motivational outcomes in patients with colon cancer.

Effects of a structured exercise program on motivational outcomes in patients with colon cancer.

Journal: Journal of the National Cancer Institute

Published: September 08, 2025

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer.

Structured Exercise after Adjuvant Chemotherapy for Colon Cancer.

Journal: The New England journal of medicine

Published: June 01, 2025

Efficacy and Safety of Bendamustine-Rituximab for Nodular Lymphocyte Predominant Hodgkin Lymphoma.

Efficacy and Safety of Bendamustine-Rituximab for Nodular Lymphocyte Predominant Hodgkin Lymphoma.

Journal: European journal of haematology

Published: April 04, 2025

Time spent in healthcare among older patients with primary central nervous system lymphoma treated with high-dose methotrexate.

Time spent in healthcare among older patients with primary central nervous system lymphoma treated with high-dose methotrexate.

Journal: Leukemia & lymphoma

Published: March 11, 2025

PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study.

PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study.

Journal: Blood

Published: February 18, 2025

A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma.

A Canadian Perspective on Systemic Therapy for Recurrent or Metastatic Nasopharyngeal Carcinoma.

Journal: Current oncology (Toronto, Ont.)

Published: December 11, 2024

De-escalated Induction Therapy and Thiotepa/Busulfan-based Autologous Stem Cell Transplantation for Primary Central Nervous System Lymphoma.

De-escalated Induction Therapy and Thiotepa/Busulfan-based Autologous Stem Cell Transplantation for Primary Central Nervous System Lymphoma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: October 09, 2024

Nutritional characterization of patients with oropharyngeal cancers: impact of human papillomavirus status.

Nutritional characterization of patients with oropharyngeal cancers: impact of human papillomavirus status.

Journal: European journal of clinical nutrition

Published: July 25, 2024

Importance of long-term follow-up of autologous stem cell transplantation for mantle cell lymphoma.

Importance of long-term follow-up of autologous stem cell transplantation for mantle cell lymphoma.

Journal: Leukemia & lymphoma

Published: July 05, 2024

Showing 1-12 of 47

Last Updated: 09/26/2026